- Präsentationen
- Dokumente
- Infografiken
CCO immune checkpoint_inhibitors_in_cancer_care
Adonis Guancia
•
Vor 8 Jahren
Oncology Immunotherapy - Nivolumab and other PD-1/PD-L1 Targeted Agents (061213)
Will Roettger
•
Vor 10 Jahren
PD1 & PD L1 Targeted Agents - Nivolumab Clinical & Commercial Development (110113)
Will Roettger
•
Vor 10 Jahren
Immuno-Oncology: A Colloquium on the State of the Science for Oncology Clinicians
Institute For Medical Education and Research (IMER)
•
Vor 11 Jahren
The immune checkpoint landscape in 2015: combination therapy
Paul D. Rennert
•
Vor 9 Jahren
RATIONAL COMBINATION IMMUNOTHERAPY: The best of ASCO16 clinical data
Paul D. Rennert
•
Vor 7 Jahren